神经外科术后颅内感染病原菌及miR-92b、miR-21、CXCL10、PCT联合检测诊断价值

Pathogenic bacteria and diagnostic value of combined detection of miR-92b, miR-21, CXCL10 and PCT in intracranial infections after neurosurgery

  • 摘要:
    目的 探讨神经外科术后颅内感染致病菌药敏分析及微小核糖核酸-92b(miR-92b)、微小核糖核酸-21(miR-21)、CXC趋化因子配体10(CXCL10)、降钙素原(PCT)联合检测的临床意义。
    方法 选取2019年10月-2023年12月在攀枝花市中心医院接受治疗的神经外科术后颅内感染患者(97例)为感染组,同期收治的神经外科术后无颅内感染患者(106例)为未感染组;比较两组临床资料、miR-92b、miR-21、CXCL10、PCT水平,分析神经外科术后颅内感染致病菌分布及主要致病菌的药敏情况,并采用受试者工作特征(ROC)曲线分析miR-92b、miR-21、CXCL10、PCT联合检测对神经外科术后颅内感染的诊断价值。
    结果 感染组有糖尿病史、脑脊液外漏、脑室外引流、低蛋白血症的患者占比分别为29.90%、75.26%、52.58%、23.71%,均高于未感染组;感染组手术时间、术后留置引流管时间分别为(4.87±0.23)h、(28.54±1.03)h,均长于未感染组;感染组术前格拉斯哥昏迷评分(GCS)为(6.03±0.36),低于未感染组(P < 0.05);97例感染组患者共分离出病原菌103株,革兰阳性菌占比为41.75%,革兰阴性菌占比为57.28%,主要为鲍曼不动杆菌(24.27%),真菌占比为0.97%;鲍曼不动杆菌对磺胺甲噁唑/甲氧苄啶、环丙沙星、多黏菌素的耐药性较低,耐药率分别为44.00%、40.00%、0;相比于未感染组,感染组脑脊液miR-92b、miR-21、CXCL10、PCT水平均更高(P < 0.05);miR-92b、miR-21、CXCL10、PCT及联合检测诊断神经外科术后颅内感染的曲线下面积(AUC)分别为0.718、0.743、0.664、0.781和0.913,其中联合检测的AUC最高(P < 0.05)。
    结论 脑脊液miR-92b、miR-21、CXCL10、PCT水平检测有利于诊断神经外科术后颅内感染,联合检测可提高诊断价值,且颅内感染致病菌主要为鲍曼不动杆菌,临床可据此进行早期诊断及抗感染治疗,以改善患者预后。

     

    Abstract:
    OBJECTIVE To explore the clinical significance of antimicrobial susceptibility analysis and combined detection of microRNA (miR)-92b, miR-21, (C-X-C motif) ligand (CXCL) 10 and procalcitonin (PCT) for intracranial infections after neurosurgery.
    METHODS Ninety-seven patients with intracranial infections after neurosurgery who received treatment at Panzhihua Central Hospital from Oct. 2019 to Dec. 2023 were selected as the infection group, and 106 patients without intracranial infections admitted during the same period as the no infection group. The clinical data and levels of miR-92b, miR-21, CXCL10 and PCT of the two groups were compared; the distribution and drug sensitivity of pathogenic bacteria in postoperative intracranial infections were analyzed; the diagnostic values of combined detection of miR-92b, miR-21, CXCL10 and PCT were evaluated by receiver operating characteristic (ROC) curve analysis.
    RESULTS The patients with history of diabetes, cerebrospinal fluid leakage, extra-ventricular drainage and hypoproteinemia in the infected group accounted for 29.90%, 75.26%, 52.58% and 23.71%, respectively, which were higher than those in the uninfected group; the length of surgical and postoperative indwelling of drainage tubes in the infected group were (4.87±0.23) h and (28.54±1.03) h, respectively, both longer than those in the non-infected group; the preoperative glasgow coma scale (GCS) of the infection group was (6.03±0.36), which was lower than that of the no infection group (P < 0.05). A total of 103 strains of pathogenic bacteria were isolated from 97 infected patients, of which gram-positive bacteria accounting for 41.75% and negative bacteria 57.28%. The most common pathogens were Acinetobacter baumannii (24.27%) and fungi (0.97%); A. baumannii had low resistance to sulfamethoxazole/trimethoprim, ciprofloxacin, and polymyxin, with resistance rates of 44.00%, 40.00% and 0, respectively. Compared with the uninfected group, the levels of miR-92b, miR-21, CXCL10, and PCT in the cerebrospinal fluid of the infected group were higher (P < 0.05). The area under the curves (AUC) of miR-92b, miR-21, CXCL10, PCT and their combined detection for diagnosing intracranial infections after neurosurgery were 0.718, 0.743, 0.664, 0.781, and 0.913, respectively; the highest AUC was observed in the combined detection (P < 0.05).
    CONCLUSIONS The combined detection of miR-92b, miR-21, CXCL10 and PCT in cerebrospinal fluid is beneficial for diagnosing intracranial infections after neurological surgery with raised diagnostic values. The dominant pathogenic bacteria of intracranial infections is A. baumannii, which can promote clinical diagnosis and anti-infective treatment and further improve the patients′ prognosis.

     

/

返回文章
返回